“The arrival of this unprecedented ‘alien’ life form could in time have far-reaching ethical, legal and regulatory implications,”
Scientists reported Wednesday that they had taken a significant step toward altering the fundamental alphabet of life — creating an organism with an expanded artificial genetic code in its DNA.
The accomplishment might eventually lead to organisms that can make medicines or industrial products that cells with only the natural genetic code cannot.
The scientists behind the work at the Scripps Research Institute have already formed a company to try to use the technique to develop new antibiotics, vaccines and other products, though a lot more work needs to be done before this is practical.
The work also gives some support to the concept that life can exist elsewhere in the universe using genetics different from those on Earth.
“This is the first time that you have had a living cell manage an alien genetic alphabet,” said Steven A. Benner, a researcher in the field at the Foundation for Applied Molecular Evolution in Gainesville, Fla., who was not involved in the new work.
But the research, published online by the journal Nature, is bound to raise safety concerns and questions about whether humans are playing God. The new paper could intensify calls for greater regulation of the budding field known as synthetic biology, which involves the creation of biological systems intended for specific purposes.
“The arrival of this unprecedented ‘alien’ life form could in time have far-reaching ethical, legal and regulatory implications,” Jim Thomas of the ETC Group, a Canadian advocacy organization, said in an email. “While synthetic biologists invent new ways to monkey with the fundamentals of life, governments haven’t even been able to cobble together the basics of oversight, assessment or regulation for this surging field.”
Despite the great diversity of life on Earth, all species, from simple bacteria to human beings, use the same genetic code. It consists of four chemical units in DNA, sometimes called nucleotides or bases, that are usually represented by the letters A, C, G and T. The sequence of these chemical units determines what proteins the cell makes. Those proteins in turn do most of the work in cells and are required for the structure, function and regulation of the body’s tissues and organs.
The Scripps researchers chemically created two new nucleotides, which they called X and Y. They inserted an X-Y pair into the common bacterium E. coli. The bacteria were able to reproduce normally, though a bit more slowly than usual, replicating the X and Y along with the natural nucleotides.
In effect, the bacteria have a genetic code of six letters rather than four, perhaps allowing them to make novel proteins that could function in a completely different way from those created naturally.
“If you have a language that has a certain number of letters, you want to add letters so you can write more words and tell more stories,” said Floyd E. Romesberg, a chemist at Scripps who led the work.
Dr. Romesberg dismissed concern that novel organisms would run amok and cause harm, saying the technique was safe because the synthetic nucleotides were fed to the bacteria. Should the bacteria escape into the environment or enter someone’s body, they would not be able to obtain the needed synthetic material and would either die or revert to using only natural DNA.
The Latest on: Synthetic biology
via Google News
The Latest on: Synthetic biology
- Team develops photosynthetic proteins for expanded solar energy conversionon March 24, 2020 at 7:55 am
The initiative is part of a broader effort in the field of synthetic biology to use proteins in place of man-made materials which are often scarce, expensive and can be harmful to the environment when ...
- A Coronavirus Vaccine Could Be the First That Outwits Natureon March 24, 2020 at 7:00 am
So. How about some good news? According to STAT, the Bill and Melinda Gates Foundation and the National Institute of Health (NIH) are betting on synthetic biology to outperform nature in engineering ...
- Polychromatic solar energy conversion in pigment-protein chimeras that unite the two kingdoms of (bacterio)chlorophyll-based photosynthesison March 24, 2020 at 3:17 am
The spectra of light used by photosynthetic organisms are determined by their pigmentation colour palettes. Here Liu et al. show that a genetically-encoded chimera of light-harvesting proteins from ...
- Announcing The Scientist's NEW 2020 Editorial Advisory Boardon March 23, 2020 at 9:00 pm
MIDLAND, Ontario, March 24, 2020 /PRNewswire-PRWeb/ -- We at The Scientist felt it was high time to revisit the purpose and benefits of maintaining an editorial advisory board. Our board members have ...
- Agricultural Biotechnology: Emerging Technologies and Global Marketson March 23, 2020 at 5:31 am
Report Scope: The study scope includes key agricultural biotechnology tools (i.e., next-generation DNA sequencing, biochips, RNA interference, synthetic biology tools and gene editing tools); ...
- This Biotech Company Is Giving $25 Million In Resources To Projects That Combat Coronaviruson March 22, 2020 at 8:31 am
$4.2 billion synthetic biology powerhouse Ginkgo Bioworks is giving $25 million worth of resources in their $400 million R&D facility to public and private teams working to cure, prevent and treat the ...
- Know How Synthetic Biology Platforms Market Is trending In Key Regions To Reach At Next Level In Coming Years?on March 18, 2020 at 12:26 am
Kenneth Research has published a detailed report on Synthetic Biology Platforms Market which has been categorized by market size, growth indicators and encompasses detailed market analysis on macro ...
- Global Synthetic Biology Marketon March 16, 2020 at 1:18 am
Synthetic biology market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 30.28 billion by 2027 growing at a ...
- Engineering of an enhanced synthetic Notch receptor by reducing ligand-independent activationon March 13, 2020 at 3:14 am
present in endogenous Notch reduces ligand-independent activation of the existing synthetic Notch receptor by 15 folds. This enhanced synthetic Notch receptor maintains its antigen-induced activation ...
- Twist Bioscience Announces Availability of Synthetic SARS-CoV-2 RNA Controlson March 12, 2020 at 5:00 am
About Twist Bioscience Corporation Twist Bioscience is a leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering ...
via Bing News